Thursday, July 08, 2010 9:05:01 AM
OTCBB: ECOC
Sectors: Chemicals; Specialty Chemicals
Investment Style: Growth
Summary:
Ecology Coatings' liquid nanotechnology™ represents a radical paradigm shift in industrial coatings technology. While others have focused efforts on improving the traditional, environmentally intensive processes, Ecology has strived for technological breakthroughs. Since 1990, Ecology has been singularly focused on developing products that enable inexpensive mass-production using materials cured under UV light to create coatings that are not only viable, but are also clean and efficient. Indeed, liquid nanotechnology™ offers a value proposition beyond compare: high-performance industrial coatings that cure in mere seconds, using 80% less floor space and 70% less energy, all while providing superior performance and eliminating harmful airborne emissions.
A publicly-traded company, Ecology is traded on the "OTC" Bulletin Board Exchange under the ticker symbol "ECOC."
History.htm
Recent ABVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 01:27:45 PM
- AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share • GlobeNewswire Inc. • 04/18/2024 01:25:00 PM
- ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M • GlobeNewswire Inc. • 04/17/2024 01:00:00 PM
- ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M • GlobeNewswire Inc. • 04/10/2024 12:30:00 PM
- ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M • GlobeNewswire Inc. • 03/26/2024 12:30:00 PM
- AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars • GlobeNewswire Inc. • 03/21/2024 12:30:00 PM
- ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine • GlobeNewswire Inc. • 03/19/2024 12:30:00 PM
- ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update • GlobeNewswire Inc. • 03/14/2024 01:30:31 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/29/2024 09:32:35 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/29/2024 09:31:06 PM
- ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars • GlobeNewswire Inc. • 02/27/2024 01:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/16/2024 10:04:42 PM
- ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues • GlobeNewswire Inc. • 02/15/2024 01:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 12:59:14 AM
- ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD) • GlobeNewswire Inc. • 02/12/2024 01:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 02:30:48 PM
- ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share • GlobeNewswire Inc. • 02/08/2024 02:17:05 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/17/2024 10:01:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 10:00:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:30:12 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/12/2024 10:01:27 PM
- ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees • GlobeNewswire Inc. • 01/03/2024 12:24:57 PM
- ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study • GlobeNewswire Inc. • 12/07/2023 01:30:00 PM
- ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials • GlobeNewswire Inc. • 12/05/2023 01:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM